Cargando…

Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery

PURPOSE: To analysis factors prognostic for peritoneal metastases (PM) from colorectal cancer (CRC) treated with surgery using data from two sources and investigate the origin and effective treatment of ovarian metastases (OM). PATIENTS AND METHODS: Data from CRC patients with PM who had undergone s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chao, Wang, Jian, Zhao, Yamei, Ge, Xiaoxu, Wang, Zhanhuai, Yu, Shaojun, Song, Yongmao, Ding, Kefeng, Zhang, Suzhan, Zheng, Shu, Sun, Lifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602918/ https://www.ncbi.nlm.nih.gov/pubmed/33149668 http://dx.doi.org/10.2147/CMAR.S270830

Ejemplares similares

An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis
por: Zhao, Yamei, et al.
Publicado: (2021)

The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis
por: Zhao, Yamei, et al.
Publicado: (2019)

Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells
por: Wang, Zhanhuai, et al.
Publicado: (2017)

Factors Prognostic for Brain Metastases from Colorectal Cancer: A Single-Center Experience in China
por: Wang, Da, et al.
Publicado: (2021)

Prognostic factors for ovarian metastases in colorectal cancer patients
por: Chen, Chao, et al.
Publicado: (2021)

Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium‐induced colitis in mice
por: Chen, Haiyan, et al.
Publicado: (2021)

Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer
por: Chen, Chao, et al.
Publicado: (2020)

Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial
por: Fang, Xuefeng, et al.
Publicado: (2023)

Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling
por: Yang, Tang, et al.
Publicado: (2020)

Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer
por: Xu, Dong, et al.
Publicado: (2015)

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy
por: Yonemura, Yutaka, et al.
Publicado: (2013)

Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study
por: Yoshida, Shinya, et al.
Publicado: (2023)

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells
por: Ge, Xiaoxu, et al.
Publicado: (2019)

Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases
por: El Asmar, Antoine, et al.
Publicado: (2022)

BEX1 Promotes Imatinib-Induced Apoptosis by Binding to and Antagonizing BCL-2
por: Xiao, Qian, et al.
Publicado: (2014)

Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
por: Díez-Alonso, Manuel, et al.
Publicado: (2021)

Treatment of peritoneal metastases from colorectal cancer
por: März, Loreen, et al.
Publicado: (2015)

Colorectal peritoneal metastases: Optimal management review
por: Sánchez-Hidalgo, Juan Manuel, et al.
Publicado: (2019)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Role of aggressive surgery for peritoneal metastases
por: Elias, Dominique, et al.
Publicado: (2013)

Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
por: Chen, Haipeng, et al.
Publicado: (2021)

The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study
por: El Asmar, Antoine, et al.
Publicado: (2023)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin
por: de Gooyer, Jan Marie, et al.
Publicado: (2022)

High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy
por: Zhou, Sicheng, et al.
Publicado: (2021)

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only
por: Désolneux, Grégoire, et al.
Publicado: (2015)

Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature
por: Mo, Shaobo, et al.
Publicado: (2016)

BEX2 promotes tumor proliferation in colorectal cancer
por: Hu, Yeting, et al.
Publicado: (2017)

Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma
por: Hung, Kuo-Chen, et al.
Publicado: (2020)

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
por: Graf, Wilhelm, et al.
Publicado: (2019)

Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
por: Enblad, Malin, et al.
Publicado: (2019)

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases
por: Simkens, Geert A., et al.
Publicado: (2018)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022)

Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases
por: Klaver, Charlotte E. L., et al.
Publicado: (2017)

Prognostic value of peritoneal scar-like tissue in patients with peritoneal metastases of ovarian origin presenting for curative-intent cytoreductive surgery
por: El Asmar, Antoine, et al.
Publicado: (2023)

Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model
por: Wintjens, Anne G. W. E., et al.
Publicado: (2023)

Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)

Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4fdtc4kv55ch2posf2krugr3m